FI861655A - Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi - Google Patents

Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi Download PDF

Info

Publication number
FI861655A
FI861655A FI861655A FI861655A FI861655A FI 861655 A FI861655 A FI 861655A FI 861655 A FI861655 A FI 861655A FI 861655 A FI861655 A FI 861655A FI 861655 A FI861655 A FI 861655A
Authority
FI
Finland
Prior art keywords
acid derivatives
medicament
preparation
derivatives used
acid
Prior art date
Application number
FI861655A
Other languages
English (en)
Swedish (sv)
Other versions
FI94133B (fi
FI861655A0 (fi
FI94133C (fi
Inventor
Masakatsu Kaneko
Yoshinobu Murofushi
Misako Kimura
Mitsuo Yamazaki
Yasuteru Iijima
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI861655A0 publication Critical patent/FI861655A0/fi
Publication of FI861655A publication Critical patent/FI861655A/fi
Priority to FI921238A priority Critical patent/FI90427C/fi
Publication of FI94133B publication Critical patent/FI94133B/fi
Application granted granted Critical
Publication of FI94133C publication Critical patent/FI94133C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI861655A 1985-04-19 1986-04-18 Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi FI94133C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI921238A FI90427C (fi) 1985-04-19 1992-03-20 Välituotteina käytettävät N'-alkoksi- tai N'-aralkyylioksi-N6-syano-griseoliinihapon johdannaiset

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP8213285 1985-04-19
JP8213285 1985-04-19
JP9198785 1985-04-27
JP9198985 1985-04-27
JP9198985 1985-04-27
JP9198785 1985-04-27

Publications (4)

Publication Number Publication Date
FI861655A0 FI861655A0 (fi) 1986-04-18
FI861655A true FI861655A (fi) 1986-10-20
FI94133B FI94133B (fi) 1995-04-13
FI94133C FI94133C (fi) 1995-07-25

Family

ID=27303820

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861655A FI94133C (fi) 1985-04-19 1986-04-18 Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi

Country Status (11)

Country Link
US (5) US5498819A (fi)
EP (1) EP0214708B1 (fi)
KR (1) KR930007385B1 (fi)
AT (2) ATE121097T1 (fi)
CA (1) CA1267409A (fi)
DE (3) DE3650429T2 (fi)
DK (1) DK167878B1 (fi)
ES (4) ES8802054A1 (fi)
FI (1) FI94133C (fi)
HK (2) HK1005738A1 (fi)
NO (1) NO169901C (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90428C (fi) * 1987-12-02 1994-02-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten griseoliinihappomonoesterijohdannaisten valmistamiseksi
US5091431A (en) * 1988-02-08 1992-02-25 Schering Corporation Phosphodiesterase inhibitors
US4971972A (en) * 1989-03-23 1990-11-20 Schering Corporation Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
JPH04112889A (ja) * 1990-09-04 1992-04-14 Kyowa Hakko Kogyo Co Ltd Ks―505誘導体
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
CA2238283C (en) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US6558787B1 (en) * 1999-12-27 2003-05-06 Kodak Polychrome Graphics Llc Relation to manufacture of masks and electronic parts
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
US7342884B2 (en) * 2002-03-13 2008-03-11 Harmonic, Inc. Method and apparatus for one directional communications in bidirectional communications channel
US20040043014A1 (en) * 2002-08-30 2004-03-04 Hiroyoshi Moriyama Platelet aggregation inhibitor and supplement food effective for inhibiting platelet aggregation
US20050130971A1 (en) * 2003-08-22 2005-06-16 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and phosphodiesterase inhibitor for the treatment of ischemic mediated central nervous system disorders or injury
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
US20110190192A1 (en) * 2009-12-15 2011-08-04 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
KR102204379B1 (ko) 2013-08-12 2021-01-19 사우디 베이식 인더스트리즈 코포레이션 올레핀 중합용 촉매 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035370A (en) * 1971-11-03 1977-07-12 Richter Gedeon Vegyeszeti Gyar Rt. Alkaloid esters
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
JPS5668695A (en) * 1979-11-10 1981-06-09 Sankyo Co Ltd Enzyme inhibitor griseolic acid and its preparation
US4803271A (en) * 1982-02-01 1989-02-07 Syntex (U.S.A.) Inc. Process for preparing guanine derivatives
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体
US4783532A (en) * 1983-10-28 1988-11-08 Sankyo Company Limited Process for preparing griseolic acid derivatives
JPS60246396A (ja) * 1984-05-22 1985-12-06 Sankyo Co Ltd 酵素阻害物質ジヒドロデスオキシグリゼオ−ル酸及びその塩類
US4788190A (en) * 1986-12-24 1988-11-29 Schering Corporation 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds
US5091431A (en) * 1988-02-08 1992-02-25 Schering Corporation Phosphodiesterase inhibitors
US4966912A (en) * 1989-09-29 1990-10-30 Uniroyal Chemical Company, Inc. Fungicidal 3-imino-1,4-oxathiins
EP0492430A1 (en) * 1990-12-27 1992-07-01 Nippon Kayaku Kabushiki Kaisha Oxetanocin derivative having imidazole base group
JPH0639472B2 (ja) * 1991-12-21 1994-05-25 メルシャン株式会社 アゾール誘導体

Also Published As

Publication number Publication date
NO169901B (no) 1992-05-11
DK167878B1 (da) 1993-12-27
EP0214708A3 (en) 1987-08-26
FI94133B (fi) 1995-04-13
DE3650429T2 (de) 1996-06-13
ES8802054A1 (es) 1988-03-16
US5532369A (en) 1996-07-02
ES8801665A1 (es) 1988-02-16
ES554178A0 (es) 1988-03-16
NO169901C (no) 1992-08-19
FI861655A0 (fi) 1986-04-18
ES557558A0 (es) 1988-02-16
US5498819A (en) 1996-03-12
EP0214708A2 (en) 1987-03-18
DE3650297T2 (de) 1996-01-25
KR860008206A (ko) 1986-11-14
HK1005739A1 (en) 1999-01-22
DE3650297D1 (de) 1995-05-18
DE3650429D1 (de) 1995-11-30
ES8801666A1 (es) 1988-02-16
US5760042A (en) 1998-06-02
US5616600A (en) 1997-04-01
ATE129501T1 (de) 1995-11-15
DK179586D0 (da) 1986-04-18
ATE121097T1 (de) 1995-04-15
FI94133C (fi) 1995-07-25
CA1267409A (en) 1990-04-03
EP0214708B1 (en) 1989-12-13
DK179586A (da) 1986-10-20
US5556975A (en) 1996-09-17
KR930007385B1 (ko) 1993-08-09
DE3667470D1 (de) 1990-01-18
ES8801664A1 (es) 1988-02-16
HK1005738A1 (en) 1999-01-22
ES557559A0 (es) 1988-02-16
ES557560A0 (es) 1988-02-16
NO861533L (no) 1986-11-21

Similar Documents

Publication Publication Date Title
FI861655A (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi
FI92399B (fi) Menetelmä lääkeaineena käyttökelpoisen tiatsolidinonin johdannaisen valmistamiseksi
ES2130111T3 (es) Derivados de ciclohexano, preparaciones que los contienen y su utilizacion.
DE68918406D1 (de) Xanthinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
EP0294069A3 (en) Purine compounds, process for their preparation, intermediates and pharmaceutical compositions
EP0319050A3 (en) Griseolic acid derivatives, their preparation and their use
PT82634A (en) Process for preparing novel alkaloid compounds containing a berban skeleton useful as medicaments
FI885638A0 (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihappomonoesterijohdannaisten valmistamiseksi
ATE43606T1 (de) Verbindungen mit cardiotropischer aktivitaet, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
RU93005243A (ru) Производные гризеоловой кислоты
ES8406488A3 (es) Procedimiento para la preparacion de derivados de norescopolamina racemicos u opticamente activos.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: SANKYO COMPANY LIMITED